The recent disruptions in global supply have highlighted the value of securing vital medications like Ivermectin. Dependence on overseas manufacturers exposes countries to significant vulnerabilities, including transportation delays, cost fluctuations, and even geopolitical threats. Transitioning towards domestic procurement of Ivermectin offers a